Active Ingredient(s):Mitapivat Sulfate FDA Approved: * February 17, 2022 Pharm Company: *AGIOS PHARMS INC Category:Anemia
Mitapivat, sold under the brand name Pyrukynd, is a medication used to treat hemolytic anemia. It is taken as the sulfate hydrate salt by mouth.
Mitapivat is a pyruvate kinase activator.
Mitapivat was approved for medical use in the United States in February 2022.
1 Medical uses
2.1 Mechanism of action
3 Society and culture
* May have multiple approval dates, manufacturers, or labelers.